Ladenburg Thalmann Financial Services’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-50
| Closed | -$1K | – | 5419 |
|
|
2019
Q1 | $1K | Hold |
50
| – | – | ﹤0.01% | 5119 |
|
|
2018
Q4 | $1K | Sell |
50
-559
| -92% | -$11.2K | ﹤0.01% | 5095 |
|
|
2018
Q3 | $14K | Buy |
+609
| New | +$14K | ﹤0.01% | 4117 |
|
|
2017
Q4 | – | Sell |
-1,134
| Closed | -$20K | – | 5126 |
|
|
2017
Q3 | $20K | Buy |
1,134
+609
| +116% | +$10.7K | ﹤0.01% | 3688 |
|
|
2017
Q2 | $9K | Sell |
525
-20,000
| -97% | -$343K | ﹤0.01% | 4090 |
|
|
2017
Q1 | $287K | Buy |
20,525
+334
| +2% | +$4.67K | ﹤0.01% | 1664 |
|
|
2016
Q4 | $322K | Buy |
20,191
+191
| +1% | +$3.05K | ﹤0.01% | 1504 |
|
|
2016
Q3 | $333K | Hold |
20,000
| – | – | 0.01% | 1425 |
|
|
2016
Q2 | $224K | Hold |
20,000
| – | – | ﹤0.01% | 1609 |
|
|
2016
Q1 | $167K | Hold |
20,000
| – | – | ﹤0.01% | 1729 |
|
|
2015
Q4 | $186K | Hold |
20,000
| – | – | ﹤0.01% | 1635 |
|
|
2015
Q3 | $226K | Sell |
20,000
-8,600
| -30% | -$97.2K | ﹤0.01% | 1409 |
|
|
2015
Q2 | $363K | Hold |
28,600
| – | – | 0.01% | 1224 |
|
|
2015
Q1 | $266K | Sell |
28,600
-575
| -2% | -$5.35K | 0.01% | 1383 |
|
|
2014
Q4 | $418K | Hold |
29,175
| – | – | 0.01% | 1010 |
|
|
2014
Q3 | $303K | Hold |
29,175
| – | – | 0.01% | 1008 |
|
|
2014
Q2 | $472K | Hold |
29,175
| – | – | 0.01% | 804 |
|
|
2014
Q1 | $474K | Sell |
29,175
-825
| -3% | -$13.4K | 0.01% | 745 |
|
|
2013
Q4 | $372K | Sell |
30,000
-1,500
| -5% | -$18.6K | 0.01% | 807 |
|
|
2013
Q3 | $345K | Buy |
31,500
+1,500
| +5% | +$16.4K | 0.01% | 806 |
|
|
2013
Q2 | $242K | Buy |
+30,000
| New | +$242K | 0.01% | 898 |
|